Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Copland

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Lancet. Oncology|September 16, 2015
Will the revised class waiver list make it?Gilles Vassal, Patricia Blanc, Chris Copland, et al.
BMJ Open|September 23, 2016
Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in UK cancer clinical trials: the EPiC study protocolKhaled Ahmed, Derek Kyte, Thomas Keeley, et al.
BMJ Open|February 13, 2018
Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocolAmeeta Retzer, Thomas Keeley, Khaled Ahmed, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2016
Implementation of mechanism of action biology-driven early drug development for children with cancerAndrew D J Pearson, Ralf Herold, Raphaël Rousseau, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Nathalie Gaspar, Katherine Janeway, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Lancet. Oncology|September 16, 2015
Will the revised class waiver list make it?Gilles Vassal, Patricia Blanc, Chris Copland, et al.
BMJ Open|September 23, 2016
Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in UK cancer clinical trials: the EPiC study protocolKhaled Ahmed, Derek Kyte, Thomas Keeley, et al.
BMJ Open|February 13, 2018
Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocolAmeeta Retzer, Thomas Keeley, Khaled Ahmed, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2016
Implementation of mechanism of action biology-driven early drug development for children with cancerAndrew D J Pearson, Ralf Herold, Raphaël Rousseau, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Nathalie Gaspar, Katherine Janeway, et al.
Pageof 1